Literature DB >> 31446053

Cytochrome P450 2E1-deficient MRL+/+ mice are less susceptible to trichloroethene-mediated autoimmunity: Involvement of oxidative stress-responsive signaling pathways.

Gangduo Wang1, Maki Wakamiya2, Jianling Wang1, G A Shakeel Ansari1, M Firoze Khan3.   

Abstract

Reactive trichloroethene (TCE) metabolites and oxidative stress are involved in TCE-mediated autoimmunity, as evident from our earlier studies in MRL+/+ mice. However, molecular mechanisms underlying the autoimmunity remain largely unknown. Cytochrome P450 2E1 (CYP2E1), the major enzyme responsible for TCE metabolism, could contribute to TCE-induced toxic response through free radical generation. The current study was, therefore, aimed to further evaluate the significance of TCE metabolism leading to oxidative stress and autoimmune response by using MRL+/+ mice that lack CYP2E1. The Cyp2e1-null MRL+/+ mice were generated by backcrossing Cyp2e1-null mice (B6N; 129S4-Cyp2e1) to MRL +/+ mice. Female MRL+/+ and Cyp2e1-null MRL+/+ mice were given TCE (10 mmol/kg, i.p., every 4th day) for 6 weeks; their respective controls received corn oil only. TCE treatment in MRL+/+ mice induced oxidative stress, evident from significantly increased serum malondiadelhyde (MDA)-protein adducts, their antibodies and reduced liver GSH levels. TCE treatment also modulated Nrf2 pathway with decreased Nrf2 and HO-1, and elevated NF-κB (p65) expression in the liver. TCE exposure also led to increases in serum antinuclear antibodies (ANA) and anti-double stranded DNA antibodies (anti-dsDNA). Although TCE treatment in Cyp2e1-null MRL+/+ mice also led to increases in serum MDA-protein adducts and their antibodies, changes in liver GSH, Nrf2, HO-1 and NF-κB along with increases in serum ANA, anti-dsDNA, the alterations in the oxidative stress and autoimmunity markers in these mice were less pronounced compared to those in MRL+/+ mice. These findings support the contribution of CYP2E1-mediated TCE metabolism in autoimmune response and an important role of Nrf2 pathway in TCE-mediated autoimmunity.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoantibodies; Autoimmunity; Cytochrome P450 2E1; Nrf2; Oxidative stress; Trichloroethene

Mesh:

Substances:

Year:  2019        PMID: 31446053      PMCID: PMC6848790          DOI: 10.1016/j.freeradbiomed.2019.08.022

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  66 in total

1.  Anti-malondialdehyde antibodies in MRL+/+ mice treated with trichloroethene and dichloroacetyl chloride: possible role of lipid peroxidation in autoimmunity.

Authors:  M F Khan; X Wu; G A Ansari
Journal:  Toxicol Appl Pharmacol       Date:  2001-01-15       Impact factor: 4.219

2.  Environmental Agents, Oxidative Stress and Autoimmunity.

Authors:  M Firoze Khan; Gangduo Wang
Journal:  Curr Opin Toxicol       Date:  2017-10-26

Review 3.  Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach.

Authors:  Antonio Cuadrado; Gina Manda; Ahmed Hassan; María José Alcaraz; Coral Barbas; Andreas Daiber; Pietro Ghezzi; Rafael León; Manuela G López; Baldo Oliva; Marta Pajares; Ana I Rojo; Natalia Robledinos-Antón; Angela M Valverde; Emre Guney; Harald H H W Schmidt
Journal:  Pharmacol Rev       Date:  2018-04       Impact factor: 25.468

4.  Protein adducts of malondialdehyde and 4-hydroxynonenal contribute to trichloroethene-mediated autoimmunity via activating Th17 cells: dose- and time-response studies in female MRL+/+ mice.

Authors:  Gangduo Wang; Jianling Wang; Xiuzhen Fan; G A S Ansari; M Firoze Khan
Journal:  Toxicology       Date:  2011-12-09       Impact factor: 4.221

Review 5.  Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity.

Authors:  Felicity D Herrington; Ruaidhrí J Carmody; Carl S Goodyear
Journal:  J Biomol Screen       Date:  2015-11-23

Review 6.  An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment.

Authors:  Nadine Keleku-Lukwete; Mikiko Suzuki; Masayuki Yamamoto
Journal:  Antioxid Redox Signal       Date:  2017-10-20       Impact factor: 8.401

7.  Editor's Highlight: Comparative Dose-Response Analysis of Liver and Kidney Transcriptomic Effects of Trichloroethylene and Tetrachloroethylene in B6C3F1 Mouse.

Authors:  Yi-Hui Zhou; Joseph A Cichocki; Valerie Y Soldatow; Elizabeth H Scholl; Paul J Gallins; Dereje Jima; Hong-Sik Yoo; Weihsueh A Chiu; Fred A Wright; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2017-11-01       Impact factor: 4.849

8.  Trichloroethene-induced autoimmune response in female MRL +/+ mice.

Authors:  M F Khan; B S Kaphalia; B S Prabhakar; M F Kanz; G A Ansari
Journal:  Toxicol Appl Pharmacol       Date:  1995-09       Impact factor: 4.219

9.  Nuclear factor erythroid 2-related factor 2 is a critical target for the treatment of glucocorticoid-resistant lupus nephritis.

Authors:  Shin Ebihara; Hideaki Tajima; Masao Ono
Journal:  Arthritis Res Ther       Date:  2016-06-14       Impact factor: 5.156

10.  Molecular mechanism of trichloroethylene-induced hepatotoxicity mediated by CYP2E1.

Authors:  Doni Hikmat Ramdhan; Michihiro Kamijima; Naoyasu Yamada; Yuki Ito; Yukie Yanagiba; Daichi Nakamura; Ai Okamura; Gaku Ichihara; Toshifumi Aoyama; Frank J Gonzalez; Tamie Nakajima
Journal:  Toxicol Appl Pharmacol       Date:  2008-05-02       Impact factor: 4.460

View more
  2 in total

1.  Urinary Malondialdehyde (MDA) and N-Acetyl-β-D-Glucosaminidase (NAG) Associated with Exposure to Trichloroethylene (TCE) in Underground Water.

Authors:  Wen-Yu Lin; Chun-Ping Tu; Hsien-Hua Kuo; Hsien-Wen Kuo
Journal:  Toxics       Date:  2022-05-29

2.  The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics.

Authors:  Yan Fang; Hongming Yang; Guiming Hu; Jiakun Lu; Jun Zhou; Na Gao; Yuhan Gu; Cunzhen Zhang; Jinhuan Qiu; Yuanyuan Guo; Yunfei Zhang; Qiang Wen; Hailing Qiao
Journal:  J Transl Med       Date:  2022-02-14       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.